Provided by Tiger Trade Technology Pte. Ltd.

Athira Pharma, Inc.

6.75
0.0000
Volume:- -
Turnover:495.51K
Market Cap:26.62M
PE:-0.70
High:6.75
Open:6.75
Low:6.75
Close:6.75
52wk High:8.36
52wk Low:2.20
Shares:3.94M
Float Shares:1.09M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.6552
EPS(LYR):-25.1917
ROE:-89.42%
ROA:-42.21%
PB:0.99
PE(LYR):-0.27

Loading ...

Athira Pharma Inc expected to post a loss of $1.22 a share - Earnings Preview

Reuters
·
Nov 04, 2025

ATHA Energy Corp. Files Final Short Form Prospectus to Strengthen Market Position

TIPRANKS
·
Nov 01, 2025

ATHA Energy Corp Updates Technical Disclosure for Angilak Project

TIPRANKS
·
Oct 22, 2025

ATHA Energy Corp. Advances Market Position with New Filings

TIPRANKS
·
Oct 22, 2025

Athena Gold Launches Diamond Drilling at Excelsior Springs Project

TIPRANKS
·
Oct 07, 2025

ATHA Energy Corp. Unveils Significant Uranium Discovery at Angilak Project

TIPRANKS
·
Sep 23, 2025

Mizuho Cuts Price Target on Athira Pharma to $4 From $5, Keeps Neutral Rating

MT Newswires Live
·
Sep 19, 2025

Athira Pharma Inc : Mizuho Adjusts Target Price to $4 From $5 to Reflect 10-for-1 Reverse Stock Split

THOMSON REUTERS
·
Sep 19, 2025

Athira Pharma trading halted, news pending

TIPRANKS
·
Sep 18, 2025

BRIEF-Athira Pharma Announces Reverse Stock Split

Reuters
·
Sep 11, 2025

Athira Pharma to Implement 10-for-1 Reverse Stock Split to Boost Share Price

Reuters
·
Sep 11, 2025

Athira Pharma Inc - Announces 10-for-1 Reverse Stock Split

THOMSON REUTERS
·
Sep 11, 2025

ATHA Energy Updates Technical Reports for Key Properties

TIPRANKS
·
Sep 11, 2025

Press Release: ATHA ENERGY ANNOUNCES REVISED FINANCING TERMS

Dow Jones
·
Sep 05, 2025

Athira Pharma Unveils Promising Phase 1 Trial Results for ALS Treatment Candidate ATH-1105 at ALS Nexus 2025

Reuters
·
Aug 14, 2025

Athira Pharma Presents Ath-1105 Phase 1 Trial Results at ALS Nexus 2025

THOMSON REUTERS
·
Aug 14, 2025

Athira Pharma Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08, 2025

Athira Pharma Q2 EPS $(0.18), Inline

Benzinga
·
Aug 08, 2025

BRIEF-Athira Pharma Q2 EPS USD -0.18

Reuters
·
Aug 08, 2025

Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Aug 08, 2025